Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
amantadine
anticholinergic drugs
antihistamines
benserazide
bradykinesia
brain transplantation
carbidopa
cerebrospinal fluid
coprolalia
echolalia
enzyme inhibition
enzyme, defect
genetic neurologic disorders
Gilles de la Tourette syndrome
headbanging
hydroxyindole acetic acid 5(5HIAA)
hydroxytryptophan L-5(L-5 HTP)
L-dopa
L-dopa, drug interactions with and side effects of
L-dopa, potentiators of
Lesch-Nyhan syndrome
livedo reticularis
madopar
monoamine oxidase inhibitors
myoclonic jerks
myoclonus
Parkinson disease
Parkinson disease, on-off phenomena in
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
phenothiazine
procyclidine
pyridoxine
reserpine and reserpine like drugs
rigidity
self-mutilation
serotonin
sinemet
treatment of neurologic disorder
tremor
vitamin, multiple
Showing articles 1000 to 1050 of 1167 << Previous Next >>

Treatment of Restless Legs Syndrome & Periodic Movements During Sleep with L-Dopa:A Double-Blind, Controlled Study
Neurol 38:1845-1848, Brodeur,C.,et al, 1988

Effect of Vitamin E Deficiency on Neurologic Function in Patients with Cystic Fibrosis
J Pediatr 113:637-640, Cynamon,H.A.,et al, 1988

Cardiac Arrhythmias
In Handbook of Parkinson's Disease, W. C. Koller (ed) , Marcal Dekker, Inc, New York, 1987, p 151., , 1987

Update on Parkinson Disease
NY State J Med, 87:147-1531987., Lieberman,A.N., 1987

Controlled-Release Levodopa/Carbidopa. I. Sinemet CR3 Treatment of Response Fluctuations in Parkinson's Disease
Neurol 37:233-241, Cedarbaum,J.M.,et al, 1987

Controlled Release Levodopa Treatment of Motor Fluctuations in Parkinson's Disease
JNNP 50:194-198, Juncos,J.L.,et al, 1987

Effects of Oral Physostigmine in Alzheimer's Disease
Ann Neurol 22:306-310, Stern,Y.,et al, 1987

Phenelzine Toxicity Responsive to Dantrolene
Neurol 37:865-867, Verrilli,M.R.,et al, 1987

Vitamin E Deficiency & Neurologic Disease in Adults with Cystic Fibrosis
Ann Int Med 107:51-54, Sitrin,M.D.,et al, 1987

Adult-Onset Spinocerebellar Syndrome with Idiopathic Vitamin E Deficiency
Ann Neurol 22:84-87, Yokota,T.,et al, 1987

Lack of Tocopherol in Peripheral Nerves of Vitamin E-Deficient Patients with Peripheral Neuropathy
NEJM 317:262-265, Traber,M.G.,et al, 1987

Factors that Influence the Occurrence of Response Variations in Parkinson's Disease
Ann Neurol 22:4-7, deJong,G.J.,et al, 1987

Multi-Center Study of Parkinson Mortality with Early Versus Later Dopa Treatment
Ann Neurol 22:8-12, Diamond,S.G.,et al, 1987

Early Combination of Bromocriptine & Levodopa in the Treatment of Parkinson's Disease:A 5-Year Follow-up
Neurol 37:826-828, Rinne,U.K., 1987

Forms of Dystonia in Patients with Parkinson's Disease
Neurol 37:1009-1011, Kidron,D.&Melamed,E., 1987

Parkinson's Disease & Motor Fluctuations:Long-Acting Carbidopa. Levodopa (CR-4-Sinemet)
Neurol 37:875-878, Goetz,C.G.,et al, 1987

Controlled-Release Levodopa/Carbidopa. II. Sinemet CR4 Treatment of Response Fluctuations in Parkinson's Disease
Neurol 37:1607-1612, Cedarbaum,J.M.,et al, 1987

Controlled Release Levodopa-Carbidopa (CR-5) in the Management of Parkinsonian Motor Fluctuations
Arch Neurol 44:1010-1012, Juncos,J.L.,et al, 1987

Dietary Influence on the Antiparkinsonian Response to Levodopa
Arch Neurol 44:1003-1005, Juncos,J.L.,et al, 1987

Levodopa Methyl Ester Treatment of Parkinson's Disease
Neurol 37:1242-1245, Juncos,J.L.,et al, 1987

Physostigmine Improves ECT-Induced Memory Disturbances
Neurol 37:871-875, Levin,Y.,et al, 1987

Peripheral Neuropathy Associated with Monoclonal IgM Autoantibody
Ann Neurol 22:764-767, Steck,A.J.,et al, 1987

Acetazolamide-Responsive Myotonia Congenita
Neurol 37:488-491, Trudell,R.G.,et al, 1987

Progression of Parkinson's Disease Without Levodopa
Neurol 37:695-698, Coetz,C.G.,et al, 1987

Classification of Parkinsonism
in Handbook of Parkinson's Disease, Marcel Dekker, Inc, New York, Ch 3, p 61., Koller,W.C., 1987

Hereditary Dystonia-Parkinsonism Syndrome of Juvenile Onset
Neurol 36:1424-1428, Nygaard,T.C.&Duvoisin,R.C., 1986

Immunologic Responses of Progressive Multiple Sclerosis Patients Treated with an Anti-T-Cell Monoclonal Antibody
Neurol 36:777-784, Hafler,D.A.,et al, 1986

MPTP:A Neurotoxin Relevant to the Pathophysiology of Parkinson's Disease, The 1985 George Cotzias Lecture
Neurol 36:250-258, Snyder,S.H.&D'Amato,R.J., 1986

Electrophysiologic Features of Abetalipoproteinemia:Functional Consequences of Vitamin E Deficiency
Neurol 36:669-673, Brin,M.F.,et al, 1986

Initiation of Levodopa Therapy in Parkinsonisn Patients Should be Delayed Until the Advanced Stages of the Disease
Arch Neurol 43:402-407, Melamen,E., 1986

Modification of Parkinson's Disease by Long-Term Levodopa Treatment
Arch Neurol 43:405-407, Markham,C.H.&Diamond,S.G., 1986

Painful Parkinson's Disease
Lancet 1:1366-1369, Quinn,N.P.,et al, 1986

The Spectrium of Neurologic Disorder From Vitamin E Deficiency
Neurol 36:917-921, Satya-Murti,S.,et al, 1986

Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer Type
NEJM 315:1241-1245, Summers,W.K.,et al, 1986

Levodopa in Restless Legs
Lancet 2:426-427, vonScheele,C., 1986

Positive Response to Edrophonium in Patients with Neurotoxic Envenoming by Cobras (NAJA NAJA PHILIPPINENIS)
NEJM 315:1444-1448, Watt,G.,et al, 1986

Dystonia-Parkinson Syndrome:Differential Effects of Levodopa and Dopamine Agonists
Clin Neuropharmacol 9:298-302, Klawans,H.L.&Paleologos,N., 1986

Improved Neurologic Function After Long-Term Correction of Vitamin E Deficiency in Children with Chronic Cholestasis
NEJM 313:1580-1586, Sokol,R.J.,et al, 1985

A Neuroleptic Malignantlike Syndrome Due to Levodopa Therapy Withdrawal
JAMA 254:2792-2795, Friedman,J.H.,et al, 1985

Vitamin E Deficiency Associated with Vision Loss & Bulbar Weakness
Ann Neurol 18:725-727, Larsen,P.D.,et al, 1985

Development of Malignant Melanoma after Levodopa Therapy for Parkinson's Disease, Report of Case & Review
Am J Med 79:119-121, Kochar,A.S., 1985

Levodopa & Melanoma:Three Cases & Review of Literature
JNNP 48:585-588, Rampen,F.H.J., 1985

Hyperthermia after Discontinuance of Levodopa & Bromocriptine Therapy:Impaired Dopamine Receptors a Possible Cause
Neurol 35:258-261, Figa-Talamanca,L.,et al, 1985

L-Dopa-Induced Respiratory Disturbance in Parkinson's Disease Suppressed by Tiapride
Neurol 35:235-237, DeKeyser,J.,et al, 1985

Low Dosages of Bromocriptine Added to Levodopa in Parkinson's Disease
Neurol 35:199-206, Maier,M.M.,et al, 1985

Pathologic Laughing & Crying Treated with Levodopa
Arch Neurol 41:1095-1096, Udaka,F.,et al, 1984

Diagnostic Importance of Immunological Markers in Lymphoma Involving the Central Nervous System
Ann Neurol 16:668-672, Ezrin-Waters,C.,et al, 1984

Chronic Low-Dose Levodopa Therapy in Parkinson's Disease:An Argument for Delaying Levodopa Therapy
Neurol 34:991-996, Rajput,A.H.,et al, 1984

Use of Monoclonal Antibody Panel to Identify Malignant Cells in Cerebrospinal Fluid
Lancet 1:1095-1098, Coakham,H.B.,et al, 1984

Drug-Induced Seizures:A 10-Year Experience
Neurol 34:1582-1586, Messing,R.O.,et al, 1984



Showing articles 1000 to 1050 of 1167 << Previous Next >>